Therapeutic Dilemmas in PK/PD, Pneumonia and Multi-Drug Resistance: Crossroads Between ID and ICU

Sunday, December 2, 2012
1:00 PM – 3:00 PM

Planned in cooperation with the ASHP New Practitioners Forum
Activity #: 204-000-12-312-L01P
Level of Content: Advanced
2.00 Contact Hours / Application-based
Program Chair: Simon W. Lam, PharmD, BCPS

Learning Objectives:

• Identify antibiotic pharmacokinetic differences in critically ill patients and the development of dosing regimens to meet pharmacodynamic goals.
• Apply recent evidence in hospital acquired pneumonia, healthcare associated pneumonia, and ventilator associated pneumonia to optimize patient pharmacotherapy.
• Evaluate the epidemiological trends, risk factors, and treatments of multi-drug resistant gram negative pathogens.
• Assess the role of early antifungal therapy in critically ill patients.